Authors


Malavika Prabhu, MD

Latest:

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.


Kartik K. Venkatesh, MD, PHD

Latest:

Diagnosis and Management of Gestational Diabetes

What every OB/GYN needs to know to manage this complication.


Jeffrey Bendix

Latest:

COVID-19's impact on patient portal utilization and disparities

A recent study analyzing patient portal use amidst the COVID-19 pandemic unveils changes in sociodemographic trends and disparities, highlighting shifts in user behavior and access challenges.


Kristi Rosa

Latest:

FDA approves dostarlimab for dMMR endometrial cancer

The FDA has granted a regular approval to dostarlimab-gxly (Jemperli; GSK) for adult patients with mismatch repair–deficient, recurrent or advanced endometrial cancer that has progressed on or after a prior platinum-containing regimen in any setting and who are not candidates for curative surgery or radiation.


Joseph Biggio, MD, MS

Latest:

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.


Holly A. Rankin, MD

Latest:

Combined hormonal contraceptives merit risk assessment in patients with obesity

Combined hormonal contraceptives such as the combined oral contraceptive pill, the patch, and the vaginal ring each have unique considerations for use in patients with obesity.


Courtney Marabella

Latest:

Niraparib Demonstrates PFS Benefit in Chinese Population With Advanced Ovarian Cancer

First-line maintenance treatment with the PARP inhibitor niraparib yielded a clinically meaningful and statistically significant improvement in progression-free survival vs placebo in Chinese patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status, according to data from the phase 3 PRIME trial.


Tiffany Avery, MD

Latest:

Treatment validation platforms can reduce care variations and promote health equity

Emerging technology helps ensure best practices while reducing costs of care.


S. Diane Yamada, MD

Latest:

Clues to the origins of ovarian cancer

Family history assessment, genetic screening are key to prevention.


Deborah A. Koehn, MD

Latest:

Statin use in midlife women

Risk assessment, lifestyle counseling, adverse effects, and medication management.


Michael S. Jellinek, MD

Latest:

Helping parents cope with adolescent behavior

A teenager’s day-to-day behavior can vary greatly. Here are some tips for understanding and navigating this challenging time.


Anne-Marie Amies Oelschlager, MD

Latest:

Uterine anomalies in pregnancy

Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.


Mike Hennessy Jr, President & CEO

Latest:

Bladder health month

Review bladder disorders and management methods you can discuss with your patients.


Caitlin Delaney, MD

Latest:

Addressing burnout before impacting your family

Today is Physician Family Day, the perfect time to reflect and address any potential burnout symptoms and spend quality time re-engaging with your loved ones.


David Kimball, MD

Latest:

Demystifying AVMs

Risk assessment and management of brain arteriovenous malformations in pregnancy.


Aislinn Antrim

Latest:

Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma

New trial results showed statistically significant improvements in overall survival and progression-free survival.


Joe Nadglowski

Latest:

COVID-19 delays cancer screenings, deaths expected to rise in next 10 years

Cancer programs seek to remove barriers to screenings.


Harold Bays, MD

Latest:

Contraception: Hopes for the Future

Kate White, MD, MPH, and Harold Bays, MD, discuss their hopes for the future of contraception options, affordability, and clinical trials evaluating their efficacy.


Richard Payerchin

Latest:

New over-the-counter continuous glucose monitoring systems launched

Abbott's Lingo and Libre Rio CGM devices, designed for general health and Type 2 diabetes management respectively, receive FDA approval, offering advanced metabolic health tracking for US consumers.


William Davies, PhD

Latest:

An update on the presentation, nosology, and causes of postpartum psychosis

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.


Shabnam Gupta, MD

Latest:

Radiofrequency ablation for fibroids

Understanding the technology behind a newer uterus-sparing option for the management of uterine fibroids.


Yazmeen Tembunde

Latest:

Sex differences in dermatologic conditions

Data has indicated an increased prevalence of atopic dermatitis among female patients compared to male patients.


Ayman Al-Hendy, MD, PhD

Latest:

The Management of Chronic Gynecologic Conditions During COVID and Beyond

Experts discuss management of women’s health including chronic pelvic pain resulting from endometriosis and heavy menstrual bleeding from uterine fibroids. They also discuss ways to help improve patient-provider communications and overcome the normalization associated with non-malignant gynecological conditions.


Chelsea Chase, MS4

Latest:

Choosing the right pill

Oral contraceptive pills are a popular choice for many; providers should understand the options to guide patients effectively.


Brian Iriye, MD

Latest:

Payment models put the value in value-based care

In this month's Practice Matters column, James D. Keller, MD, MHSA; and Brian K. Iriye, MD, explore the world of value-based care and how it can benefit your practice.


Colleen Moretti

Latest:

Frequent use of neoadjuvant chemotherapy may further benefit patients with advanced ovarian cancer

Treatment programs that often use neoadjuvant chemotherapy as a strategy may help prolong survival in patients with advanced ovarian cancer compared with those that infrequently used the tactic, which may reassure patients and providers.


Gaby Moawad, MD, F.A.C.O.G.

Latest:

Surgeons Panel Discussion

Three esteemed surgeons discuss technology, weighing the pros and cons of existing and newly developed platforms.


Allison August, MD

Latest:

Historical Difficulty in Safely and Effectively Preventing CMV

Experts discuss the trajectory of CMV awareness and vaccine development efforts.


Zoe Wainer, MBBS, PhD

Latest:

Mind-body resilience for women: A focus on depression

Here’s why we should be paying special attention to women’s depression treatment.


Benjamin M. Brucker, MD

Latest:

EP. 15: Subsequent Treatment Considerations for Patients with Unsatisfactory Responses to Third-Line Therapy for OAB

Experts close their panel on OAB by identifying treatment pathways for patients who have an unsatisfactory response to third-line therapy.

© 2024 MJH Life Sciences

All rights reserved.